Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-box transcription factor 4 (TBX4) is a DNA-binding transcription factor from the T-box gene family that regulates gene expression critical for embryonic development, especially in the formation of hindlimbs and organs such as the lungs and pelvis[1][2][6]. TBX4 is essential for limb bud initiation and specifies hindlimb identity in vertebrates[1][2]. Its action is influenced by Hox gene expression and further interacts with the Wnt signaling pathway and fibroblast growth factors to drive developmental patterning. TBX4 mutations are implicated in rare developmental disorders including small patella syndrome, pulmonary arterial hypertension (most notably in children), and more severe forms of limb and pulmonary agenesis. TBX4 is primarily a transcriptional regulator, not a classical receptor or enzyme, and is expressed in mesenchymal tissues during organogenesis[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-box transcription factor 4 (TBX4).